University of Pittsburgh Medical Center Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Pittsburgh Medical Center Cancer Institute has participated in 3 clinical trials.
Therapeutic areas: Non-Hodgkin's Lymphoma (NHL), Metastatic Renal Cell Carcinoma, Colorectal Neoplasms.
Sponsors: Cephalon, NewLink Genetics Corporation, National Center for Complementary and Integrative Health (NCCIH).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Pittsburgh
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pittsburgh Medical Center Cancer Institute has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pittsburgh Medical Center Cancer Institute has 3 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma (NHL), Metastatic Renal Cell Carcinoma, Colorectal Neoplasms.
University of Pittsburgh Medical Center Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.